Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China
· Delayed Price · Currency is CNY 4.940
-0.020 (-0.40%)
Apr 30, 2026, 9:55 AM CST
SHE:000597 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,078 | 7,449 | 7,531 | 7,646 | 9,051 | 8,384 | Upgrade
|
| Market Cap Growth | -6.72% | -1.09% | -1.49% | -15.52% | 7.95% | 22.43% | Upgrade
|
| Enterprise Value | 5,156 | 5,445 | 4,778 | 5,667 | 7,484 | 8,815 | Upgrade
|
| Last Close Price | 4.96 | 5.22 | 5.17 | 5.13 | 5.95 | 5.85 | Upgrade
|
| PE Ratio | 28.37 | 28.64 | 18.38 | 21.33 | 25.84 | 84.66 | Upgrade
|
| Forward PE | - | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | Upgrade
|
| PS Ratio | 0.99 | 1.05 | 1.00 | 0.93 | 1.03 | 1.03 | Upgrade
|
| PB Ratio | 1.25 | 1.31 | 1.35 | 1.48 | 1.92 | 1.95 | Upgrade
|
| P/TBV Ratio | 1.49 | 1.58 | 1.68 | 1.79 | 2.37 | 2.42 | Upgrade
|
| P/FCF Ratio | 6.65 | 7.39 | 12.57 | 21.76 | 10.47 | 13.38 | Upgrade
|
| P/OCF Ratio | 6.13 | 6.73 | 9.93 | 13.03 | 8.16 | 11.23 | Upgrade
|
| EV/Sales Ratio | 0.72 | 0.77 | 0.64 | 0.69 | 0.85 | 1.08 | Upgrade
|
| EV/EBITDA Ratio | 6.76 | 7.09 | 4.66 | 6.22 | 9.92 | 12.20 | Upgrade
|
| EV/EBIT Ratio | 21.67 | 21.09 | 10.04 | 15.48 | 34.09 | 41.85 | Upgrade
|
| EV/FCF Ratio | 4.84 | 5.40 | 7.97 | 16.13 | 8.66 | 14.07 | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.37 | 0.29 | 0.42 | 0.47 | 0.58 | Upgrade
|
| Debt / EBITDA Ratio | 2.52 | 2.66 | 1.52 | 2.32 | 2.81 | 3.27 | Upgrade
|
| Debt / FCF Ratio | 1.80 | 2.09 | 2.66 | 6.21 | 2.54 | 3.97 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.26 | -0.52 | -0.67 | -0.35 | -0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.78 | -1.94 | -2.80 | -3.80 | -2.18 | -0.09 | Upgrade
|
| Net Debt / FCF Ratio | -1.93 | -1.48 | -4.80 | -9.87 | -1.91 | -0.10 | Upgrade
|
| Asset Turnover | 0.53 | 0.52 | 0.51 | 0.57 | 0.65 | 0.64 | Upgrade
|
| Inventory Turnover | 3.77 | 3.71 | 3.53 | 3.97 | 4.50 | 4.04 | Upgrade
|
| Quick Ratio | 0.96 | 0.95 | 0.87 | 0.86 | 0.78 | 0.65 | Upgrade
|
| Current Ratio | 1.15 | 1.15 | 1.05 | 1.02 | 0.94 | 0.83 | Upgrade
|
| Return on Equity (ROE) | 3.52% | 3.88% | 7.89% | 7.62% | 7.93% | 2.27% | Upgrade
|
| Return on Assets (ROA) | 1.09% | 1.18% | 2.00% | 1.57% | 1.02% | 1.04% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.53% | 5.36% | 15.47% | 11.86% | 4.09% | 3.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 4.10% | 7.70% | 6.40% | 4.10% | 4.20% | Upgrade
|
| Earnings Yield | 3.54% | 3.49% | 5.44% | 4.69% | 3.87% | 1.18% | Upgrade
|
| FCF Yield | 15.05% | 13.54% | 7.96% | 4.59% | 9.55% | 7.47% | Upgrade
|
| Dividend Yield | 1.11% | 1.05% | 1.93% | 1.95% | 1.68% | 0.24% | Upgrade
|
| Payout Ratio | 70.79% | 75.71% | 50.30% | 61.31% | 31.25% | 167.14% | Upgrade
|
| Buyback Yield / Dilution | -2.23% | -2.23% | 1.43% | -2.34% | 0.97% | -15.42% | Upgrade
|
| Total Shareholder Return | -1.13% | -1.18% | 3.37% | -0.40% | 2.65% | -15.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.